Prevention And Treatment Of VTE In COVID-19: Where Do We Stand?

Venous thromboembolism (VTE) affects almost 5-15% of patients hospitalized for medical or surgical complaints. 1 Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is spreading rapidly around the globe since its first outbreak in Wuhan, China. In patients with COVID-19 infection, a potential link between mortality, D-dimer values, and a prothrombotic syndrome has been reported. In context to this, let’s discuss the prevention and treatment Of VTE in the COVID-19 outbreak.

2 In this regard, Sanofi and Docplexus have organized an International Webinar on 27 th May 2020 at 4:30 PM. In this webinar, the international experts' panel in the venous thromboembolism (VTE) will share their experiences and discuss  “Prevention And Treatment Of VTE In COVID-19: Where Do We Stand?” References Zhai Z, et al., Chest. 2019 Jan…